References
- Vazquez‐Mellado J., Alvarez Hernandez E., Burgos‐Vargas R. Primary prevention in rheumatology: the importance of hyperuricemia. Best Pract Res Clin Rheumatol 2004; 18: 111–24
- Becker B. F. Towards the physiological function of uric acid. Free Radical Biol Med 1993; 14: 615–31
- Fam A. G. Gout: excess calories, purines and alcohol intake and beyond. Response to a urate‐lowering diet. J Rheumatol 2005; 32: 773–76
- Waring W. S., Convery A. A., Mishra V., Shenkin A., Webb D. J., Maxwell S. R. Uric acid reduces exercise‐induced oxidative stress in healthy adults. Clin Sci 2003; 105: 425–30
- Kanellis J., Feig D. I., Johnson R. J. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology 2004; 9: 394–9
- Fang J., Alderman M. H. Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow‐up study, 1971–1992. J Am Med Assoc 2000; 283: 2404–10
- Anker S. D., Doehner W., Rauchhaus M., Sharma R., Francis D., Knosalla C., et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. Circulation 2003; 107: 1951–3
- Hoskison T. K., Wortmann R. L. Advances in the management of gout and hyperuricaemia. Scand J Rheumatol 2006; 35: 251–60
- Aarflot T., Laerum E., Bruusgaard D. Uric acid and chronic musculoskeletal complaints. Scand J Rheumatol 1992; 21: 277–82
- Andersson H. I., Ejlertsson G., Leden I., Rosenberg C. Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol 1996; 25: 146–54
- Aarflot T., Bruusgaard D. Chronic musculoskeletal complaints and subgroups with special reference to uric acid. Scand J Rheumatol 1994; 23: 25–9
- Afzal N., Mahmud T. E., Jahan S. S., Kundi S. Uric acid profile in patients with chronic nonspecific musculoskeletal pain. J Ayub Med Coll Abbottabad 2003; 15: 5–9
- Clauw D. J., Crofford L. J. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003; 17: 685–701
- Schultes B., Schmid S., Peters A., Born J., Fehm H. L. Sleep loss and the development of diabetes: a review of current evidence. Exp Clin Endocrinol Diabetes 2005; 113: 563–7
- Rogers N. L., Szuba M. P., Staab J. P., Evans D. L., Dinges D. F. Neuroimmunologic aspects of sleep and sleep loss. Semin Clin Neuropsychiatry 2001; 6: 295–307
- Saito H., Nishimura M., Shibuya E., Makita H., Tsujino I., Miyamoto K., et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest 2002; 122: 1686–94
- Niskanen L. K., Laaksonen D. E., Nyyssonen K., Alfthan G., Lakka H. M., Lakka T. A., et al. Uric acid level as a risk factor for cardiovascular and all‐cause mortality in middle‐aged men: a prospective cohort study. Arch Intern Med 2004; 164: 1546–51
- Durak I., Kacmaz M., Cimen M. Y., Buyukkocak U., Ozturk H. S. Blood oxidant/antioxidant status of atherosclerotic patients. Int J Cardiol 2001; 77: 293–7
- Ozturk H. S., Cimen M. Y., Cimen O. B., Kacmaz M., Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999; 19: 35–7
- Wood P. B. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypotheses 2004; 62: 420–4
- MacFarlane G. J., McBeth J., Silman A. J. Widespread body pain and mortality: prospective population based study. Br Med J 2001; 323: 1–5
- Andersson H. I. The course of non‐malignant chronic pain: a 12‐year follow‐up of a cohort from the general population. Eur J Pain 2004; 8: 47–53